Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Non-Current Deferred Tax Liability (2016 - 2023)

Anika Therapeutics (ANIK) has disclosed Non-Current Deferred Tax Liability for 14 consecutive years, with $2.0 million as the latest value for Q3 2023.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 71.25% to $2.0 million in Q3 2023 year-over-year; TTM through Sep 2023 was $2.0 million, a 71.25% decrease, with the full-year FY2022 number at $6.4 million, down 36.63% from a year prior.
  • Non-Current Deferred Tax Liability was $2.0 million for Q3 2023 at Anika Therapeutics, down from $3.2 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $16.0 million in Q1 2020 to a low of $2.0 million in Q3 2023.
  • A 5-year average of $8.4 million and a median of $8.2 million in 2022 define the central range for Non-Current Deferred Tax Liability.
  • Peak YoY movement for Non-Current Deferred Tax Liability: skyrocketed 373.14% in 2020, then plummeted 71.25% in 2023.
  • Anika Therapeutics' Non-Current Deferred Tax Liability stood at $4.3 million in 2019, then skyrocketed by 174.65% to $11.9 million in 2020, then decreased by 14.61% to $10.2 million in 2021, then crashed by 36.63% to $6.4 million in 2022, then plummeted by 69.62% to $2.0 million in 2023.
  • Per Business Quant, the three most recent readings for ANIK's Non-Current Deferred Tax Liability are $2.0 million (Q3 2023), $3.2 million (Q2 2023), and $4.1 million (Q1 2023).